IL-4 Protein 組換え体(リコンビナント)タンパク質 | Recombinant Human IL-4 Protein
掲載日情報:2018/02/07 現在Webページ番号:215978
R&D Systems社製の高品質なIL-4 Proteinの組換え体タンパク質(Recombinant Human IL-4 Protein)です。
※本製品は研究用です。研究用以外には使用できません。
[在庫・価格 :2025年12月14日 00時00分現在]
| 詳細 | 商品名 |
|
文献数 | ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Recombinant Human IL-4 Protein |
|
0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
[在庫・価格 :2025年12月14日 00時00分現在]
Recombinant Human IL-4 Protein
文献数: 0
- 商品コード:204-IL-500
- メーカー:RSD
- 包装:500μg
- 価格:ご照会ください
- 在庫:無(未発注)
- 納期:10日程度 ※※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。
- 法規制等:
| 説明文 | 純度:>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.,由来動物:Human,M.W.:15 kDa,Genbank:3565,エンドトキシンレベル:<0.10 EU per 1 µg of the protein by the LAL method.,産生:E. coli 別名:B cell growth factor 1 Genbank No: 3565 Protein Accession No: P05112 |
||
|---|---|---|---|
| 法規制等 | |||
| 保存条件 | -20℃ | 法規備考 | |
| 掲載カタログ |
|
||
| 製品記事 | 抗幹細胞マーカー抗体/抗造血幹細胞マーカー抗体(R&D Systems社) Helper T Cells Marker Antibodies |
||
| 関連記事 | R&D Systems 製品WHO Unit Conversion Table |
||
追加しました。
バルク注文に関して
※バルク包装品も承ります。お気軽にお問合せ下さい。
追加しました。
CF(Carrier-Free)とは?
R&D Systems社組換え体タンパク質製品では通常ウシ血清アルブミン(BSA)をキャリアタンパク質として加えています。キャリアタンパク質を加えることで組換え体タンパク質の安定性が高まり、使用期限が長くなります。また、より濃度の低い溶液での保管も可能となります。CF製品はBSAが含まれない製品となります。一般的に細胞培養や、ELISAのスタンダードにはBSA含有製品を推奨しています。CF製品はBSAが影響してしまうアプリケーションに推奨されます。
追加しました。
Product Details
- Source
- E. coli-derivedHis25-Ser153, with an N-terminal Met
- Accession #
- P05112
- Purity
- >97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
- Predicted Molecular Mass
- 15 kDa
- SDS-PAGE
- 14 kDa, reducing conditions
- Activity
- Measured in a cell proliferation assay using TF‑1 human erythroleukemic cells. Kitamura, T. et al. (1989) J. Cell Physiol. 140:323. The ED50 for this effect is 0.05-0.2 ng/mL.The specific activity of recombinant human IL-4 is approximately 2.9 x 104 IU/μg, which is calibrated against human IL-4 WHO International Standard (NIBSC code: 88/656).
- Bioactivity

- Recombinant Human IL-4 (Catalog # 204-IL) stimulates cell proliferation of the TF-1 human erythroleukemic cell line. The ED50 for this effect is 0.05-02 ng/mL.
- SDS-PAGE
追加しました。
Related Product & Information
- Entrez Gene IDs
- 3565 (Human); 16189 (Mouse); 287287 (Rat); 397225 (Porcine); 280824 (Bovine); 403785 (Canine); 574281 (Primate); 100302454 (Rabbit)
- Background
- IL-4
- Interleukin-4 (IL-4), also known as B cell-stimulatory factor-1, is a monomeric, approximately 13 kDa‑18 kDa Th2 cytokine that shows pleiotropic effects during immune responses (1‑3). It is a glycosylated polypeptide that contains three intrachain disulfide bridges and adopts a bundled four alpha -helix structure (4). Human IL-4 is synthesized with a 24 aa signal sequence. Alternate splicing generates an isoform with a 16 aa internal deletion. Mature human IL-4 shares 55%, 39% and 43% aa sequence identity with bovine, mouse, and rat IL-4, respectively. Human, mouse, and rat IL-4 are species-specific in their activities (5‑7). IL-4 exerts its effects through two receptor complexes (8, 9). The type I receptor, which is expressed on hematopoietic cells, is a heterodimer of the ligand binding IL-4 R alpha and the common gamma chain (a shared subunit of the receptors for IL-2, -7, -9, -15, and ‑21). The type II receptor on nonhematopoietic cells consists of IL-4 R alpha and IL‑13 R alpha 1. The type II receptor also transduces IL-13 mediated signals. IL-4 is primarily expressed by Th2-biased CD4+ T cells, mast cells, basophils, and eosinophils (1, 2). It promotes cell proliferation, survival, and immunoglobulin class switch to IgG4 and IgE in human B cells, acquisition of the Th2 phenotype by naïve CD4+ T cells, priming and chemotaxis of mast cells, eosinophils, and basophils, and the proliferation and activation of epithelial cells (10‑13). IL-4 plays a dominant role in the development of allergic inflammation and asthma (12, 14).
追加しました。
Citations
The data collected includes not only links to publications in PubMed,
but also provides information about sample types, species, and experimental conditions.
Authors: M Yoshida, Y Ishioka, T Ozawa, H Okuyama, M Iguchi, T Ota, T Ito, M Nagira, A Morita, H Tanaka, H Naito, H Kidoya, N Takakura
Sci Rep, 2017;7(1):11137.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: J Wang, H Ye, D Zhang, K Cheng, Y Hu, X Yu, L Lu, J Hu, C Zuo, B Qian, Y Yu, S Liu, G Liu, C Mao, S Liu
Theranostics, 2017;7(6):1407-1421.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: MA Schumacher, M Hedl, C Abraham, JK Bernard, PR Lozano, JJ Hsieh, D Almohazey, EB Bucar, S Punit, PJ Dempsey, MR Frey
Cell Death Dis, 2017;8(2):e2622.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: C Guntermann, A Piaia, ML Hamel, D Theil, T Rubic-Schn, A Del Rio-Es, L Dong, A Billich, K Kaupmann, J Dawson, K Hoegenauer, D Orain, S Hintermann, R Stringer, DD Patel, A Doelemeyer, M Deurinck, J Schümann
JCI Insight, 2017;2(5):e91127.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: H Zan, C Tat, Z Qiu, JR Taylor, JA Guerrero, T Shen, P Casali
Nat Commun, 2017;8(0):14244.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: A Pichugin, OV Iarovaia, A Gavrilov, I Sklyar, N Barinova, A Barinov, E Ivashkin, G Caron, S Aoufouchi, SV Razin, T Fest, M Lipinski, YS Vassetzky
Oncotarget, 2017;0(0):.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: J Huang, F Shen, H Huang, C Ling, G Zhang
Oncotarget, 2017;8(8):13116-13125.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: S Mehrotra, CD Britten, S Chin, E Garrett-Ma, CA Cloud, M Li, G Scurti, ML Salem, MH Nelson, MB Thomas, CM Paulos, AM Salazar, MI Nishimura, MP Rubinstein, Z Li, DJ Cole
J Hematol Oncol, 2017;10(1):82.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: CSB Viegas, RM Costa, L Santos, PA Videira, Z Silva, N Araújo, AL Macedo, AP Matos, C Vermeer, DC Simes
PLoS ONE, 2017;12(5):e0177829.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: S Inogés, S Tejada, AL de Cerio, JG Pérez-Larr, J Espinós, MA Idoate, PD Domínguez, RG de Eulate, J Aristu, M Bendandi, F Pastor, M Alonso, E Andreu, FP Cardoso, RD Valle
J Transl Med, 2017;15(1):104.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: C Li, Y Bi, Y Li, H Yang, Q Yu, J Wang, Y Wang, H Su, A Jia, Y Hu, L Han, J Zhang, S Li, W Tao, G Liu
Nat Commun, 2017;8(0):14275.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: G Izumi, K Koga, M Takamura, W Bo, M Nagai, M Miyashita, M Harada, T Hirata, Y Hirota, O Yoshino, T Fujii, Y Osuga
J. Immunol., 2017;0(0):.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: J Helft, F Anjos-Afon, AG van der Ve, P Chakravart, D Bonnet, C Reis E Sou
Cell Rep, 2017;20(3):529-537.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: L Sarmiento, J De Rosa, A Machicote, LA Billordo, P Baz, PM Fernández, I Kaimen Mac, A Blanco, EI Arana
Sci Rep, 2017;7(1):11077.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: SC Silva-Card, AJ Affandi, L Spel, M Cossu, JAG van Roon, M Boes, TRDJ Radstake
J. Immunol., 2017;0(0):.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: J Zeitvogel, N Jokmin, S Rieker, I Klug, C Brandenber, T Werfel
Sci Rep, 2017;7(1):11847.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: JY Ao, XD Zhu, ZT Chai, H Cai, YY Zhang, KZ Zhang, LQ Kong, N Zhang, BG Ye, DN Ma, HC Sun
Mol. Cancer Ther., 2017;0(0):.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: DJ Son, YY Jung, MH Park, HL Lee, MJ Song, HS Yoo, DY Hwang, SB Han, JT Hong
Neoplasia, 2017;19(7):537-548.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: AM Clemente, G Castronovo, A Antonelli, MM D'Andrea, M Tanturli, E Perissi, S Paccosi, A Parenti, F Cozzolino, GM Rossolini, MG Torcia
PLoS ONE, 2017;12(6):e0178847.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: F Kawamura, M Inaki, A Katafuchi, Y Abe, N Tsuyama, Y Kurosu, A Yanagi, M Higuchi, S Muto, T Yamaura, H Suzuki, H Noji, S Suzuki, MA Yoshida, M Sasatani, K Kamiya, M Onodera, A Sakai
Sci Rep, 2017;7(1):1659.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: K Mahiddine, A Mallaviall, H Bziouech, F Larbret, A Bernard, G Bernard
Eur J Immunol, 2016;0(0):.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: Edaire Cheng
PLoS ONE, 2016;11(6):e0157376.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
PLoS ONE, 2016;11(5):e0155771.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Circ Res, 2016;0(0):.
Species: Human
Sample Type: Plasma
Application: Bioassay
Mol Immunol, 2016;77(0):205-212.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Elife, 2016;5(0):.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
J Immunol, 2016;0(0):.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
PLoS ONE, 2016;11(9):e0161759.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Int J Mol Sci, 2016;17(11):.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Cancer Res, 2016;0(0):.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
PLoS ONE, 2016;11(9):e0163120.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: Huston S, Ngamskulrungroj P, Xiang R, Ogbomo H, Stack D, Li S, Timm-McCann M, Kyei S, Oykhman P, Kwon-Chung K, Mody C
J Immunol, 2016;196(3):1259-71.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: TM Garcia-Bat, E Kim, F Concha-Ben, S Trivedi, RB Mailliard, A Gambotto, RL Ferris
J. Immunol, 2016;196(6):2870-8.
Species: Mouse
Sample Type: Whole Cells
Application: Bioassay
Cancer Res, 2016;0(0):.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Sci Rep, 2016;6(0):36355.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: Shipkowski K, Taylor A, Thompson E, Glista-Baker E, Sayers B, Messenger Z, Bauer R, Jaspers I, Bonner J
PLoS ONE, 2015;10(6):e0128888.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: Eigenbrod T, Pelka K, Latz E, Kreikemeyer B, Dalpke A
J Immunol, 2015;195(3):1092-9.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: Martner A, Wiktorin H, Lenox B, Ewald Sander F, Aydin E, Aurelius J, Thoren F, Stahlberg A, Hermodsson S, Hellstrand K
J Immunol, 2015;194(10):5014-21.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: Wang J, Cao Z, Zhang X, Nakamura M, Sun M, Hartman J, Harris R, Sun Y, Cao Y
Cancer Res, 2015;75(2):306-15.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: Fichtner S, Hose D, Engelhardt M, Meissner T, Neuber B, Krasniqi F, Raab M, Schonland S, Ho A, Goldschmidt H, Hundemer M
Clin Cancer Res, 2015;21(7):1712-21.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: Liu G, Bi Y, Xue L, Zhang Y, Yang H, Chen X, Lu Y, Zhang Z, Liu H, Wang X, Wang R, Chu Y, Yang R
Proc Natl Acad Sci U S A, 2015;112(9):E957-65.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
Authors: Berlin C, Kowalewski D, Schuster H, Mirza N, Walz S, Handel M, Schmid-Horch B, Salih H, Kanz L, Rammensee H, Stevanovic S, Stickel J
Leukemia, 2015;29(3):647-59.
Species: Human
Sample Type: Whole Cells
Application: Bioassay
追加しました。
製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。

